ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Polymyalgia Rheumatica (PMR)"

  • Abstract Number: 0794 • ACR Convergence 2020

    Peripheral Blood T and B Lymphocyte Subsets in Arthritis in the Elderly

    Aina Teniente-Serra1, Lourdes Mateo2, Agueda Prior3, Monica Guma4, Eva Martinez-Caceres1 and Melania Martinez-Morillo5, 1Department of Immunology, Germans Trias i Pujol. University Hospital, Badalona, Badalona, 2Department of Rheumatology, Germans Trias i Pujol. University Hospital, Badalona, Badalona, 3Department of Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, 4Division of Rheumatology, University of California San Diego, Department of Medicine, Autonomous University of Barcelona, La Jolla, CA, 5Hospital Germans Trias i Pujol, Barcelona, Spain

    Background/Purpose: Multiple lymphocyte subsets like T and B cells have been connected to joint infiltration and inflammation in rheumatoid arthritis (RA). Identification of leucocyte subsets…
  • Abstract Number: 1580 • ACR Convergence 2020

    Generalized Immune Activation in Structures Related to PMR or GCA on PET/CT Assessment Does Not Occur in Immune Checkpoint Inhibitor-Treated Patients Who Do Not Go on to Develop Rheumatic Immune-Related Adverse Events

    David Liew1, Aurora Poon2, Christopher McMaster3, Claire Owen4, Jessica Leung5, Albert Frauman2, Jonathan Cebon6, Andrew Scott6 and Russell Buchanan7, 1Austin Health, Melbourne, Victoria, Australia, Heidelberg, Victoria, Australia, 2Austin Health, Melbourne, Victoria, Australia, Melbourne, Victoria, Australia, 3Austin Health, Melbourne, Victoria, Australia, Pascoe Vale South, Victoria, Australia, 4Austin Health, Melbourne, Victoria, Australia, Ashburton, Victoria, Australia, 5Austin Health, Melbourne, Victoria, Australia, Melbourne, 6Austin Health, Melbourne, Victoria, Australia, Melbourne, Australia, 7Austin Health, Melbourne, Victoria, Australia, Heidelberg, Melbourne, Victoria, Australia

    Background/Purpose: The pathogenesis of rheumatic immune-related adverse events (irAEs) from checkpoint inhibitor cancer immunotherapy directed against programmed cell death protein 1 (PD-1) and programmed death…
  • Abstract Number: 1934 • ACR Convergence 2020

    What Is the Significance of Periarterial Temporal Small Vessel Inflammation (SVI) on Temporal Artery Biopsy (TAB) in the Diagnosis of Vasculitis? A Systematic Review and Meta-analysis

    Elise Belilos1, Steven Carsons2 and Sonya Mehta1, 1NYU Winthrop Hospital, Mineola, NY, 2NYU Long Island School of Medicine, Mineola, NY

    Background/Purpose: Isolated inflammation of small vessels including capillaries, venules and arterioles surrounding a normal temporal artery (SVI) in patients suspected of having giant cell arteritis…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology